EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Role of metabolic reprogramming of cancer‑associated fibroblasts in tumor development and progression (Review)

Ruyue Li, Yintao Li

International Journal of Oncology · 2025

DOI: 10.3892/ijo.2025.5796 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2025. Verfasst von Ruyue Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong 261053, P.R. China. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Tumor Microenvironment, Neoplasms, Cellular Reprogramming. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The occurrence and development of tumors is affected by tumor cells themselves and various components of the tumor microenvironment (TME). Among these, cancer‑associated fibroblasts (CAFs), the main stromal component, can differentiate from different cell types and play an important role in the TME. The present review summarized the role of the metabolic reprogramming of CAFs in tumor development and progression. As the rapid growth of tumors is a process inseparable from energy supply and the TME is characterized by hypoxia and nutrient deficiencies, metabolic reprogramming can reverse the effects of a lack of energy supply in the TME. Studies have found that CAFs can affect tumor proliferation, migration, invasion, metastasis and drug resistance by changing metabolic patterns. The present review promoted research on the metabolic reprogramming of CAFs and emphasized the importance of considering the heterogeneity and plasticity of CAFs in the TME, which will lead to the development of more effective therapeutic strategies that target specific metabolic pathways in CAFs, potentially improving the efficacy of cancer treatments and overcoming drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer-Associated FibroblastsTumor MicroenvironmentNeoplasmsCellular ReprogrammingHumansDisease ProgressionDrug Resistance, NeoplasmAnimalsCell ProliferationEnergy MetabolismMetabolic Reprogramming

Stichwörter der Autor:innen

amino acidcancer‑associated fibroblastsglycolysislipidmetabolic reprogrammingtumor

Autor:innen und Institutionen

  • School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong 261053, P.R. China.
  • Department of Medical Oncology, Shandong Cancer Hospital and Institute, Jinan, Shandong 250117, P.R. China.

Zitieren

APA

Li, R., & Li, Y. (2025). Role of metabolic reprogramming of cancer‑associated fibroblasts in tumor development and progression (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2025.5796

Vancouver

Li R, Li Y. Role of metabolic reprogramming of cancer‑associated fibroblasts in tumor development and progression (Review). International Journal of Oncology. 2025. doi:10.3892/ijo.2025.5796

BibTeX
@article{Li2025,
  author = {Li, Ruyue and Li, Yintao},
  title = {Role of metabolic reprogramming of cancer‑associated fibroblasts in tumor development and progression (Review)},
  journal = {International Journal of Oncology},
  year = {2025},
  doi = {10.3892/ijo.2025.5796}
}
Kostenlos starten →